We have located links that may give you full text access.
Inhibiting Pneumococcal Surface Antigen A (PsaA) with Small Molecules Discovered Through Virtual Screening: Steps Toward Validating A Potential Target for Streptococcus pneumoniae.
Chemistry & Biodiversity 2018 September 18
The pneumococcal surface antigen A (PsaA) metal transporter protein provides manganese to bacterial cells. X-ray crystal structures of PsaA, in both closed (Mn bound) and open (metal free) conformations, were explored with virtual screening to identify potential inhibitors of manganese transport. We pursued three strategies for inhibition: 1) targeting a cavity close to the bound Mn to keep the metal in-place; 2) targeting the metal-free Mn site to prevent metal uptake; and 3) targeting a potentially druggable allosteric site involving loops that translate between the conformations. Tiered assays were used to test the resulting 170 acquired hits: a) assay 1 tested the compounds' growth inhibition of the TIGR4 S. pneumoniae strain (ΔpsaA mutant control), yielding 80 compounds (MIC ≤ 250 μM); b) assay 2 tested if addition of 20 μM Mn to inhibited cell cultures restored growth, yielding 21 compounds; and c) assay 3 confirmed that restored bacterial growth was Mn concentration dependent, as was restoration of ΔpsaA growth, yielding 12 compounds with MICs of 125 μM or greater. It may be possible for a small molecule to inhibit PsaA, but we have not yet identified a compound with exemplary properties.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app